BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cao YX, Zhang M, Zhang HW, Jin JL, Liu HH, Zhang Y, Guo YL, Wu NQ, Zhu CG, Xu RX, Gao Y, Dong Q, Sun J, Li JJ. Impact of liver fibrosis score on prognosis in patients with previous myocardial infarction: A prospective cohort study. Liver Int 2021;41:1294-304. [PMID: 33389804 DOI: 10.1111/liv.14780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Martínez-Urbistondo D, de la Garza RG, Villares-Fernández P, Font C, Schellong S, López-Núñez JJ, Gil-Díaz A, Del Carmen Díaz-Pedroche M, Hirmerova J, Monreal M; RIETE Investigators. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism. Intern Emerg Med 2021. [PMID: 34626318 DOI: 10.1007/s11739-021-02858-x] [Reference Citation Analysis]
2 Kim SW, Jeon JH, Moon JS, Kim MK. High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study. Endocrinol Metab (Seoul) 2021;36:800-9. [PMID: 34418914 DOI: 10.3803/EnM.2021.1040] [Reference Citation Analysis]
3 Mantovani A, Valenti L. A call to action for fatty liver disease. Liver Int 2021;41:1182-5. [DOI: 10.1111/liv.14907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]